Isothiocyanatostilbenes as novel c-Met inhibitors

The hepatocyte growth factor receptor (HGFR or c-Met) is a driver of multiple cancer subtypes. While there are several c-Met inhibitors in development, few have been approved for clinical use, warranting the need for continued research and development of c-Met targeting therapeutic modalities. The r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Gray, Alana L., Coleman, David T., Castore, Reneau F., Mohyeldin, Mohamed M., El Sayed, Khalid A., Cardelli, James A.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2015
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747398/
https://ncbi.nlm.nih.gov/pubmed/26543230
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker